Locations:
Search IconSearch

Cancer

Researchers in lab

New Grants Boost Hereditary Breast and Ovarian Cancer Research

Understanding resistance in PARP inhibitor therapy

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

nci-vol-10540-650×450
December 27, 2018/Cancer/Research

Molecular Profiling Improves Progression-Free Survival in Patients with Pancreatic Cancer

Know Your Tumor initiative matches treatments with patients

Cancer immunotherapy. Source: National Cancer Institute.

Statistics Expert Leads National Clinical Trials Task Force

Establishing best practices for seamless trial design

Lathia, MD, in lab

Sex Differences Loom Large in Glioblastoma Development

Understanding the role of patient sex may lead to personalized therapies

Castleman disease
December 19, 2018/Cancer/News & Insight

Treatment Guidelines Established for Idiopathic Multicentric Castleman Disease

An international consensus statement on a subtype of a rare disease

Aaron Gerds, MD
December 18, 2018/Cancer/Research

NCCN Publishes Guidelines for Systemic Mastocytosis

How to care for patients with this rare, complex disease

BackPage 75 of 113Next

Advertisement

Ad